Polymorphic CA repeat in IGF-I gene: Lack of association with schizophrenia

Psychiatric Genetics

Volumn 20, Issue 1, 2010, Pages 44-45

  Bonvicini, Cristian ^a   Gennarelli, Massimo ^a,b   Scassellati, Catia ^a   Bignotti, Stefano ^a   Gardella, Rita ^b   Barlati, Sergio ^b   Valsecchi, Paolo ^c,d   Sacchetti, Emilio ^c,d,e  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c SPEDALI CIVILI   (Italy)

^d Brescia Spedali Civili ^*  (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; TANDEM REPEAT;

ADULT; ALLELES; DINUCLEOTIDE REPEATS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 75149171865     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283351167     Document Type: Letter

References (17)

1. Aberg ND, Johansson UE, Aberg MA, Hellström NA, Lind J, Bull C, et al. (2007). Peripheral infusion of insulin-like growth factor-I increases the number of newborn oligodendrocytes in the cerebral cortex of adult hypophysectomized rats. Endocrinology 148:3765-3772.
2. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40:827-834.
3. Altar CA, Hunt RA, Jurata LW, Webster M, Derby E, Gallagher P, et al. (2008). Insulin, IGF-1, and muscarinic agonist modulate schizophrenia-associated genes in human neuroblastoma cells. Biol Psychiatry 64:1077-1087.
4. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Text Revised. Washington, DC: American Psychiatric Association.
5. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structural clinical interview for DSM-IV Axis I disorders, clinician version (SCID-CV). Washington, DC: American Psychiatric Press.
6. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, Ashworth A, et al. (2005). Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14:2-19.
7. Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL, et al. (2002). A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51:2313-2316.
8. Gunnell D, Lewis S, Wilkinson J, Georgieva L, Davey GS, Day IN, et al. (2007). IGF1, growth pathway polymorphisms and schizophrenia: a pooling study. Am J Med Genet B Neuropsychiatr Genet 144:117-120.
9. Harrison PJ (2007). Schizophrenia susceptibility genes and neurodevelopment. Biol Psychiatry 61:1119-1120.
10. Nurnberger JI Jr, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, et al. (1994). Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry 51:849-859. (Pubitemid 24985906)
11. Rietveld I, Ikram MK, Vingerling JR, Hofman A, Pols HA, Lamberts SW, et al. (2006). An IGF-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes 55:2387-2391.
12. Sacchetti E, Bocchio-Chiavetto L, Valsecchi P, Scassellati C, Pasqualetti P, Bonvicini C, et al. (2007). -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: meta-analysis plus association study. Brain Behav Immun 21:450-457.
13. Sacchetti E, Galluzzo A, Valsecchi P, Romeo F, Gorini B, Warrington L (2009). Ziprasidone vs. clozapine in schizophrenia patients refractory to multiple antipsychotic treatment: The MOZART study. Schizophr Res 110:80-89.
14. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, et al. (2001). A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50:637-642.
15. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, et al. (2002). Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 359:1036-1037.
16. Venkatasubramanian G, Chittiprol S, Neelakantachar N, Naveen MN, Thirthall J, Gangadhar BN, et al. (2007). Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia. Am J Psychiatry 164:1557-1560.
17. Wooten J (2007). Metabolic effects of the atypical antipsychotics. South Med J 100:771-772.